Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Chemocentryx Inc (NQ: CCXI )

57.24 USD +0.03 (+0.05%)
Official Closing Price Updated: 5:08 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Chemocentryx Inc

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
ChemoCentryx Inc (CCXI) Q4 2020 Earnings Call Transcript
CCXI earnings call for the period ending December 31, 2020. 
Tags CCXI Market News
From Motley Fool
ChemoCentryx: Q4 Earnings Insights
Shares of ChemoCentryx (NASDAQ:CCXI) moved higherin after-market trading after the company reported Q4 results. Quarterly ... 
Tags BZI/Recaps CCXI Market News
From Benzinga
ChemoCentryx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
From GlobeNewswire News Releases
Earnings Scheduled For March 1, 2021
Companies Reporting Before The Bell • Athenex (NASDAQ:ATNX) is likely to report quarterly loss at $0.44 per share on ... 
Tags FSK AGRX THRM
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ... 
Tags NVAX Market News AQST
From Benzinga
ChemoCentryx to Present at Two Upcoming Investor Conferences
From GlobeNewswire News Releases
ChemoCentryx Appoints Tausif (‘Tosh’) Butt as Executive Vice President and Chief Operating Officer
From GlobeNewswire News Releases
ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call on Monday, March 1, 2021
From GlobeNewswire News Releases
ChemoCentryx Announces Publication in The New England Journal of Medicine of Results of the Pivotal Phase III ADVOCATE Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
From GlobeNewswire News Releases
The Math Shows IHE Can Go To $215
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SRDX CCXI AEMD
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MORF VNDA TTOO
From Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AGEN OCX IPOs
From Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags KRYS SLN LLY
From Benzinga
ChemoCentryx Larger Than S&P 500 Component Under Armour
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component ChemoCentryx, Inc. (CCXI) was identified as having a larger market cap than the smaller end of the S&P 500,... 
Tags Stocks
From Market News Video
Analysts Predict 15% Upside For The Holdings of IHE
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
ChemoCentryx to Participate in Two Upcoming Investor Conferences
From GlobeNewswire News Releases
First Week of CCXI May 21st Options Trading
Investors in ChemoCentryx, Inc. (CCXI) saw new options begin trading this week, for the May 21st expiration.. 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CRSP Small Cap EDIT
From Benzinga
42 Stocks Moving in Tuesday's Pre-Market Session
Gainers Aurora Mobile Limited (NASDAQ: JG) shares rose 56.4% to $4.99 in pre-market trading after the company reported a ... 
Tags CETX SNCA ECOR
From Benzinga
7 Stocks Moving In Monday's After-Hours Session
Gainers ZIOPHARM Oncology (NASDAQ: ZIOP) shares are trading higher after the company announced clearance of Taiwan's first IND ... 
Tags Trading Ideas ZIOP After/Hours Center
From Benzinga
ChemoCentryx and VFMCRP Provide Topline Results from ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)
From GlobeNewswire News Releases
ChemoCentryx to Present at Two Upcoming Investor Conferences
From GlobeNewswire News Releases
45 Stocks Moving in Tuesday's Pre-Market Session
Gainers Trxade Group, Inc. (NASDAQ: MEDS) rose 36.1% to $5.85 in pre-market trading after the company entered into a solution ... 
Tags CUK Premarket Movers Trading Ideas
From Benzinga
18 Stocks Moving In Monday's After-Hours Session
Gainers RingCentral (NYSE: RNG) shares are trading higher after the company reported better-than-expected Q3 EPS and sales ... 
Tags ORGO MITO XPER
From Benzinga
Recap: ChemoCentryx Q3 Earnings
Shares of ChemoCentryx (NASDAQ:CCXI) fell 8.59% in after-market trading after the company reported Q3 results. Quarterly ... 
Tags Market News CCXI Earnings
From Benzinga
ChemoCentryx Reports Third Quarter 2020 Financial Results and Recent Highlights
From GlobeNewswire News Releases
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags RGEN ADAP CDAK
From Benzinga
Earnings Outlook For ChemoCentryx
ChemoCentryx (NASDAQ:CCXI) will be releasing its next round of earnings this Monday, November 09. For all of the relevant ... 
Tags Benzinga Earnings Market News
From Benzinga
ChemoCentryx Announces Plenary Session at ACR Convergence 2020 to Highlight Findings of ADVOCATE Phase III Trial in ANCA-Associated Vasculitis
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.